New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Start Comparing ETFs Now!

›ETF Issuers›VanEck›HLTH

HLTH

VanEck Global Healthcare Leaders ETF

Passive ETF Equity

Not rated

The HLTH Exchange Traded Fund (ETF) is provided by VanEck. It is built to track an index: MarketGrader Developed Markets (ex-Australia) Health Care Index. The HLTH ETF provides physical exposure, so by buying it you actually own parts of all the 50 underlying holdings. This share class generates a stream of income by distributing dividends.

A$11.41

N/A

Data as of 07/21/26

1D price range

N/A

52W price range

A$10.62A$12.94

YTD Perf.

-5.63%

YTD Flows

Annualized volatility

Fund AuM

€31M

Share class AuM

€31M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

AU0000102683

TER

0.45%

Inception date

10/9/2020

Issuer

VanEck

Benchmark

MarketGrader Developed Markets (ex-Australia) Health Care Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
MDEV First Trust Indxx Medical Devices ETF	-2.07%
2B78 iShares Healthcare Innovation UCITS ETF	-1.15%
LIV Smart Healthcare Innovation ETF	-0.42%
GDOC Goldman Sachs Future Health Care Equity ETF	-0.92%
AGNG Global X Aging Population ETF	+0.38%
XGEN Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF	-2.90%
HRTS Tema GLP-1, Obesity & Cardiometabolic ETF	-0.20%
IHI iShares U.S. Medical Devices ETF	-0.89%
IBB iShares Biotechnology ETF	-1.46%
TDOC TD Global Healthcare Leaders Index ETF	-0.30%
CBUF iShares MSCI World Health Care Sector Advanced UCITS ETF	+0.21%
TMED T. Rowe Price Health Care ETF	0.00%
PBE Invesco Dynamic Biotechnology & Genome ETF	-0.32%
CIB0 Vaneck Bionic Engineering Ucits ETF	-3.06%
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	+0.76%

API

PerformanceDec 31, 2025 - Jul 21, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

99.95%

Latest HLTH news

No content available for this fund

FAQ about HLTH

HLTH is a Passive ETF. This ETF provides exposure to Equally Weighted Developed markets ex-Australia Health Care Equities.

HLTH tracks the MarketGrader Developed Markets (ex-Australia) Health Care Total Return Index - AUD, through a full replication replication method.

HLTH carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.

HLTH was introduced to the market on October 9, 2020. It trades on Australia

VanEck Global Healthcare Leaders ETF, HLTH, is provided by VanEck. Learn more about VanEck here.

HLTH oversees €31M in assets as of July 21, 2026.

HLTH follows a distributing dividend policy, meaning it pays out income to investors. As of July 21, 2026, its 12-month trailing yield was 0.35%.

As of June 30, 2026, HLTH has significant geographic allocations in USA, Japan and Republic of Korea.

As of June 30, 2026, HLTH focuses largely on Healthcare.

As of June 30, 2026, HLTH holds 50 positions in its portfolio, with 37.52% of assets concentrated in its top 15 holdings.

As of June 30, 2026, HLTH top three holdings include West Pharmaceutical Services, Inc., Arrowhead Pharmaceuticals, Inc. and Illumina, Inc..

The base currency of HLTH is AUD.

Top 10 holdings

Data as of 06/30/26

West Pharmaceutical Services, Inc.

2.99%

Arrowhead Pharmaceuticals, Inc.

2.90%

Illumina, Inc.

2.90%

argenx SE

2.59%

Exelixis, Inc.

2.58%

Neurocrine Biosciences, Inc.

2.54%

Ypsomed Holding AG

2.51%

Novo Nordisk A/S

2.49%

Halozyme Therapeutics, Inc.

2.41%

Incyte Corp.

2.40%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The Ultimate ETF Comparison Tool - Try Now!

VanEck Global Healthcare Leaders ETF

FAQ about HLTH

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US